SYNV-cyclo (CGGYF) (TFA)

SYNV-cyclo (CGGYF) TFA is a Staphylococcus hominis (S. hominis) C5 autoinducing peptide. SYNV-cyclo (CGGYF) TFA inhibits S. aureus activity. SYNV-cyclo (CGGYF) TFA has the potential for the research of S. aureus-mediated epithelial damage and inflammation[1].

Product Specifications

UNSPSC

12352209

Target

Bacterial

Type

Peptides

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/synv-cyclo-cggyf-tfa.html

Purity

97.08

Solubility

10 mM in DMSO

Smiles

O=C([C@@H](N)CO)N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(NCC(N[C@H](C(N[C@H]1CC2=CC=CC=C2)=O)CC3=CC=C(O)C=C3)=O)=O)=O)CSC1=O)=O)C(C)C)=O)CC(N)=O)=O)CC4=CC=C(O)C=C4.OC(C(F)(F)F)=O

Molecular Formula

C48H59F3N10O15S

Molecular Weight

1105.10

References & Citations

[1]Williams MR, et al. Quorum sensing between bacterial species on the skin protects against epidermal injury in atopic dermatitis. Sci Transl Med. 2019 May 1;11 (490) :eaat8329.